Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AMZN stock price vs ELV: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ELV's multiple
Needs ELV P/E.
Implied fair value · at AMZN's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
11 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
AMAZON.COM, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Elevance Health, Inc. · implied price per share
Bear
$158.07
Base
$203.66
Bull
$263.02
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Walmart Inc.
AMZN vs WMT
EBAY INC
AMZN vs EBAY
MICROSOFT CORP
AMZN vs MSFT
Alphabet Inc.
AMZN vs GOOGL
Apple Inc.
AMZN vs AAPL
TARGET CORP
AMZN vs TGT
UnitedHealth Group Incorporated
AMZN vs UNH
CVS Health Corporation
AMZN vs CVS
HUMANA INC
AMZN vs HUM
CENTENE CORP
AMZN vs CNC
Edwyn research
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe AMZN can sustain its current profitability and close to 12% revenue growth while maintaining its stronger balance sheet, then holding or accumulating on pullbacks may make sense because the operating quality is clearly stronger than ELV even though the provided P/E-based valuation points to a large discount from the current price.
The valuation inputs show a large gap between AMZN's current price of $274.48 and the P/E-implied price of $112.11, which suggests -59.2% downside on that method. However, AMZN also sits above the top of the DCF range and within/above the historical band, so the valuation picture is not uniformly cheap.
Supporting Metrics
